
Stuart Snyder
Examiner (ID: 19177)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648 |
| Total Applications | 524 |
| Issued Applications | 295 |
| Pending Applications | 33 |
| Abandoned Applications | 200 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7382904
[patent_doc_number] => 20040082068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Incorporation and priming function of trnalys in hiv and related viruses'
[patent_app_type] => new
[patent_app_number] => 10/432223
[patent_app_country] => US
[patent_app_date] => 2003-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 30747
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082068.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432223 | Incorporation and priming function of trnalys in hiv and related viruses | Nov 4, 2003 | Abandoned |
Array
(
[id] => 7163670
[patent_doc_number] => 20050085529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Prenylation inhibitors reduce host cell permissiveness to viral replication'
[patent_app_type] => utility
[patent_app_number] => 10/690891
[patent_app_country] => US
[patent_app_date] => 2003-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6554
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20050085529.pdf
[firstpage_image] =>[orig_patent_app_number] => 10690891
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/690891 | Prenylation inhibitors reduce host cell permissiveness to viral replication | Oct 20, 2003 | Issued |
Array
(
[id] => 260102
[patent_doc_number] => 07572828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-11
[patent_title] => 'Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid'
[patent_app_type] => utility
[patent_app_number] => 10/528747
[patent_app_country] => US
[patent_app_date] => 2003-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10633
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/572/07572828.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528747 | Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid | Oct 7, 2003 | Issued |
Array
(
[id] => 4511866
[patent_doc_number] => 07910110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'Bacteriophage-mediated immunisation against hepatitis'
[patent_app_type] => utility
[patent_app_number] => 10/529917
[patent_app_country] => US
[patent_app_date] => 2003-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 7393
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910110.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529917
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529917 | Bacteriophage-mediated immunisation against hepatitis | Oct 1, 2003 | Issued |
Array
(
[id] => 5850639
[patent_doc_number] => 20060233830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/528364
[patent_app_country] => US
[patent_app_date] => 2003-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8973
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20060233830.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528364 | Vaccines | Sep 22, 2003 | Abandoned |
Array
(
[id] => 7425431
[patent_doc_number] => 20040161431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Antibacterial therapy with bacteriophage physico-chemically altered to delay inactiovation by the host defense system'
[patent_app_type] => new
[patent_app_number] => 10/659698
[patent_app_country] => US
[patent_app_date] => 2003-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7115
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20040161431.pdf
[firstpage_image] =>[orig_patent_app_number] => 10659698
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/659698 | Antibacterial therapy with bacteriophage physico-chemically altered by pegylation to delay inactivation by the host defense system | Sep 10, 2003 | Issued |
Array
(
[id] => 7425257
[patent_doc_number] => 20040161411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Antibacterial therapy with bacteriophage genotypically modified to delay inactiovation by the host defense system'
[patent_app_type] => new
[patent_app_number] => 10/659711
[patent_app_country] => US
[patent_app_date] => 2003-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7843
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20040161411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10659711
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/659711 | Antibacterial therapy with bacteriophage genotypically modified to delay inactiovation by the host defense system | Sep 10, 2003 | Abandoned |
Array
(
[id] => 7325946
[patent_doc_number] => 20040138423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Insecticidal compounds and methods for selection thereof'
[patent_app_type] => new
[patent_app_number] => 10/655751
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9163
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138423.pdf
[firstpage_image] =>[orig_patent_app_number] => 10655751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/655751 | Insecticidal compounds and methods for selection thereof | Sep 4, 2003 | Issued |
Array
(
[id] => 7468668
[patent_doc_number] => 20040096458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Fusion protein construct and method for inducing HIV-specific serum IgG and secretory IgA antibodies in-vivo'
[patent_app_type] => new
[patent_app_number] => 10/655667
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19358
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20040096458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10655667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/655667 | Fusion protein construct and method for inducing HIV-specific serum IgG and secretory IgA antibodies in-vivo | Sep 4, 2003 | Issued |
Array
(
[id] => 6912233
[patent_doc_number] => 20050175991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Method for produce sanitation using bacteriophages'
[patent_app_type] => utility
[patent_app_number] => 10/655217
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20306
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10655217
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/655217 | Method for produce sanitation using bacteriophages | Sep 4, 2003 | Abandoned |
Array
(
[id] => 852853
[patent_doc_number] => 07378234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-27
[patent_title] => 'Method for isolating hepatitis C virus peptides'
[patent_app_type] => utility
[patent_app_number] => 10/512885
[patent_app_country] => US
[patent_app_date] => 2003-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18513
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/378/07378234.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512885
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512885 | Method for isolating hepatitis C virus peptides | Aug 26, 2003 | Issued |
Array
(
[id] => 7361953
[patent_doc_number] => 20040091498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Defensins: use as antiviral agents'
[patent_app_type] => new
[patent_app_number] => 10/452763
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 36926
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10452763
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/452763 | Defensins: use as antiviral agents | May 29, 2003 | Abandoned |
Array
(
[id] => 816993
[patent_doc_number] => 07410801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-12
[patent_title] => 'Lambda phage display system and the process'
[patent_app_type] => utility
[patent_app_number] => 10/515150
[patent_app_country] => US
[patent_app_date] => 2003-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7243
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/410/07410801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515150
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515150 | Lambda phage display system and the process | May 19, 2003 | Issued |
Array
(
[id] => 536430
[patent_doc_number] => 07173106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-06
[patent_title] => 'Insecticidal compounds and methods for selection thereof'
[patent_app_type] => utility
[patent_app_number] => 10/436324
[patent_app_country] => US
[patent_app_date] => 2003-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 8038
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/173/07173106.pdf
[firstpage_image] =>[orig_patent_app_number] => 10436324
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/436324 | Insecticidal compounds and methods for selection thereof | May 11, 2003 | Issued |
Array
(
[id] => 5716077
[patent_doc_number] => 20060079440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Treatment of hi-virus infections with oxidised blood proteins'
[patent_app_type] => utility
[patent_app_number] => 10/555423
[patent_app_country] => US
[patent_app_date] => 2003-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4435
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079440.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555423
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555423 | Treatment of hi-virus infections with oxidised blood proteins | Apr 24, 2003 | Abandoned |
Array
(
[id] => 5921421
[patent_doc_number] => 20060240028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Anti-nls substances and uses thereof in nuclear import inhibition'
[patent_app_type] => utility
[patent_app_number] => 10/511990
[patent_app_country] => US
[patent_app_date] => 2003-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11039
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240028.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511990 | Anti-nls substances and uses thereof in nuclear import inhibition | Apr 20, 2003 | Abandoned |
Array
(
[id] => 7348065
[patent_doc_number] => 20040192887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'PH-dependent polypeptide aggregation and its use'
[patent_app_type] => new
[patent_app_number] => 10/397059
[patent_app_country] => US
[patent_app_date] => 2003-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8756
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10397059
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/397059 | PH-dependent polypeptide aggregation and its use | Mar 24, 2003 | Abandoned |
Array
(
[id] => 6966413
[patent_doc_number] => 20050233310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Screening method'
[patent_app_type] => utility
[patent_app_number] => 10/506643
[patent_app_country] => US
[patent_app_date] => 2003-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6569
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20050233310.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506643 | Screening method | Mar 10, 2003 | Abandoned |
Array
(
[id] => 6770348
[patent_doc_number] => 20030216288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Methods and compositions for treating aids and HIV-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules'
[patent_app_type] => new
[patent_app_number] => 10/366288
[patent_app_country] => US
[patent_app_date] => 2003-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48725
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216288.pdf
[firstpage_image] =>[orig_patent_app_number] => 10366288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/366288 | Methods and compositions for treating aids and HIV-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules | Feb 12, 2003 | Abandoned |
Array
(
[id] => 7193102
[patent_doc_number] => 20050163787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Immunological adjuvant'
[patent_app_type] => utility
[patent_app_number] => 10/486592
[patent_app_country] => US
[patent_app_date] => 2003-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4574
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163787.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486592 | Immunological adjuvant | Feb 9, 2003 | Abandoned |